phenofAST
Formerly Tishrei Diagnostics
Antimicrobial Susceptibility Testing Solution
Startup Seed Health Tech & Life Sciences Est. 2018
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
1 rounds
Investors
1
1 public
Team
3
1-10 employees
Confidence
98/100
News
1
articles
Patents
1
About
phenofAST has developed a fast and affordable clinical diagnostic solution for antibiotic susceptibility testing, providing definitive test results within 4 hours from a positive culture. Antibiotic susceptibility tests (AST) can take 2 to 3 days to produce definitive results, and with the accelerated spread of antibiotic-resistant bacteria, inappropriate antibiotic treatment results in mortality, morbidity, and higher healthcare costs across all stakeholders. phenofAST is the only company to have completely new & innovative physics-based technology, detecting cell division through laser light interferences, powered by AI analysis. phenofASTs solution provides same day AST test results in a cost effective way for a wide range of indications. This solution is applicable to any microbiology lab due to it's modular design – fit any lab space and needs, Green, minimal waste operation and low price of disposable testing cassette. With phenofAST solution, the microbiology lab will be able to provide the physician with the AST results, enabling the physician to adjust the antibiotic treatment on the same day that the patient was admitted, minimizing AMR ( antimicrobial resistance) and maximizing the right and effective treatment needed. Clinical validations done so far provided very high agreement with the gold standard. phenofAST goal is to become the Standard of Practice in antibiotic susceptibility testing, proving fast, cost-effective and wide-range solution for healthcare providers and payers.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Core Technology
Artificial IntelligenceImage RecognitionSensingLaserOpticPlatforms & InterfacesSoftware
Target Customer
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersLaboratoriesPatientsMedical Devices IndustryMedical EquipmentLife SciencesBiotechnology
Business Model
B2B
Tags
real-timeopticsartificial-intelligencelaserssensorshealthcare-providerslaboratoriespharmaceuticals
Funding & Events
Apr 2021
Undisclosed Round Undisclosed
MindUP
News (1)
Jun 14, 2021 · www.prweb.com
growth-positive
MindUP Invests in its 14th Portfolio Company: phenofAST
Partners
Details
Product Stage
Beta
Employees
1-10
Exact Count
4
District
North District
Founded
2018
Registrar
515612885
Locations
Haifa, Israel
Links
Website
LinkedIn
Admin
Last Update
May 8, 2025
Verified by
Yotam Maman
Claimed
Yes
Missing
markets
Team (3)
Eliane Markowitz
CEO
Nadav Ben-Dov
Founder & CTO
Founder
Aviram Sariel
Co-founder
Founder
Internal
Created by
Nadav Ben-Dov (nadav.bd@phenofast.com)
Created
2021-10-31T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)